GleanMark
Biocentris Pharmaceuticals — TTAB Proceedings
Biocentris Pharmaceuticals
is a party to 1 TTAB proceedings.
Proceedings
Proceeding 92068295
— CAN (filed 2018-04-04)
Related
Biocentris Pharmaceuticals portfolio
All TTAB research tools
TTAB search